We found that the antagonist of PKR or ISR effectively reverses PVOD phenotypes in both young and aged rats, even when the antagonists were administered after the PVOD phenotypes had fully developed, which further confirms that inhibiting the PKR/ISR axis might be an effective treatment even for the advanced stage of PVOD. Here, EIF2AK2 is linked to pulmonary venoocclusive disease.